The ASC market's revenues, Dr. Farid Namin's PPE manufacturer and more — 4 GI industry notes

Listen
Text
  • Small
  • Medium
  • Large

Here are four updates from GI practices and companies over the past week:

1. The gastroenterology ASC market had revenues of $7.21 billion in 2019 and has $10.27 billion in its sights for 2027.

2. Exact Sciences provided the Kentucky Department for Public Health a grant for 1,000 Cologuard kits.

3. Gastroenterologist Farid Namin, MD, opened a personal protective equipment manufacturer after overcoming procurement obstacles early in the pandemic.

4. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test.

 

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast